We are live on ! Find out more
AP

Atwood & Palmer Portfolio holdings

AUM $1.87B
1-Year Est. Return 24.22%
This Fund
S&P 500
This Quarter Est. Return
-11.62%
1 Year Est. Return
+24.22%
3 Year Est. Return
+82.33%
5 Year Est. Return
+97.89%
10 Year Est. Return
+352.71%
AUM
$1.03B
AUM Growth
-$132M
Cap. Flow
+$20.6M
Cap. Flow %
2.01%
Top 10 Hldgs %
29.82%
Holding
462
New
17
Increased
58
Reduced
119
Closed
62

Top Buys

Rank Stock Value
1
UTHR icon
United Therapeutics
UTHR
+$11.1M
2
GEN icon
Gen Digital
GEN
+$9.34M
3
GRMN
Garmin
GRMN
+$9.3M
4
UNFI icon
United Natural Foods
UNFI
+$9.22M
5
AMGN icon
Amgen
AMGN
+$5.68M

Top Sells

Rank Stock Value
1
PFF icon
iShares Preferred and Income Securities ETF
PFF
+$8.97M
2
MA icon
Mastercard
MA
+$4.79M
3
GEM icon
Goldman Sachs ActiveBeta Emerging Markets Equity ETF
GEM
+$4.72M
4
TMO icon
Thermo Fisher Scientific
TMO
+$3.8M
5
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$3.74M

Sector Composition

Rank Sector Weight
1 Healthcare 17.34%
2 Technology 16.69%
3 Industrials 11.06%
4 Financials 10.91%
5 Consumer Discretionary 4.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FTGC icon
1
First Trust Global Tactical Commodity Strategy Fund
FTGC
$2.99B
$46.3M 4.51%
1,731,681
+171
+0% +$4.96K
GSIE icon
2
Goldman Sachs ActiveBeta International Equity ETF
GSIE
$5.86B
$34.7M 3.38%
1,248,290
+49,689
+4% +$1.5M
IMTM icon
3
iShares MSCI Intl Momentum Factor ETF
IMTM
$4.11B
$33M 3.22%
1,104,205
+46,626
+4% +$1.51M
LMT icon
4
Lockheed Martin
LMT
$134B
$32.6M 3.17%
75,752
-1,450
-2% -$637K
TMO icon
5
Thermo Fisher Scientific
TMO
$211B
$30.3M 2.96%
55,861
-6,912
-11% -$3.8M
ABBV icon
6
AbbVie
ABBV
$458B
$27.6M 2.68%
179,887
+17,251
+11% +$2.64M
CDW icon
7
CDW
CDW
$17.1B
$26M 2.53%
165,009
+156
+0.1% +$26.2K
URI icon
8
United Rentals
URI
$71.1B
$25.9M 2.53%
106,791
-215
-0.2% -$63.3K
GNRC icon
9
Generac Holdings
GNRC
$11.9B
$25.1M 2.45%
119,278
+1,354
+1% +$333K
ON icon
10
ON Semiconductor
ON
$33.8B
$24.6M 2.4%
489,016
+4,380
+0.9% +$244K
REGN icon
11
Regeneron Pharmaceuticals
REGN
$68.8B
$24.5M 2.39%
41,482
+431
+1% +$280K
AMP icon
12
Ameriprise Financial
AMP
$46.8B
$24.3M 2.36%
102,049
-486
-0.5% -$130K
GOOG icon
13
Alphabet (Google) Class C
GOOG
$3.9T
$24.1M 2.35%
220,660
-24,600
-10% -$2.91M
HOLX
14
DELISTED
Hologic
HOLX
$22.8M 2.22%
328,520
+1,144
+0.3% +$84.9K
AMGN icon
15
Amgen
AMGN
$203B
$21.4M 2.08%
87,842
+23,161
+36% +$5.68M
CSCO icon
16
Cisco
CSCO
$450B
$21.2M 2.06%
496,960
+7,876
+2% +$377K
JBBB icon
17
Janus Henderson B-BBB CLO ETF
JBBB
$1.4B
$20.9M 2.03%
457,534
+3,119
+0.7% +$149K
MA icon
18
Mastercard
MA
$477B
$20.6M 2.01%
65,410
-13,900
-18% -$4.79M
FITB
19
Fifth Third Bancorp
FITB
$52B
$20.5M 2%
610,776
+5,479
+0.9% +$206K
JAAA icon
20
Janus Henderson AAA CLO ETF
JAAA
$29.1B
$20.2M 1.96%
411,234
+2,772
+0.7% +$138K
VNLA icon
21
Janus Henderson Short Duration Income ETF
VNLA
$3.33B
$20.2M 1.96%
414,582
-7,340
-2% -$358K
SONY icon
22
Sony
SONY
$123B
$20M 1.95%
1,221,070
+12,410
+1% +$220K
AAPL icon
23
Apple
AAPL
$4.89T
$19.5M 1.9%
142,583
-21,862
-13% -$3.31M
DHI icon
24
D.R. Horton
DHI
$41B
$18.8M 1.83%
284,004
+68,942
+32% +$4.85M
PNC icon
25
PNC Financial Services
PNC
$100B
$18.7M 1.83%
118,771
-4,093
-3% -$686K
1
2 3 4 5

Similar funds

KA
Kovack Advisors Ft. Lauderdale, Florida $1.87B AUM 29.51% 1-Year Est. Return
PCP
Proficio Capital Partners Newton, Massachusetts $1.87B AUM 30.54% 1-Year Est. Return
JPG
Jordan Park Group San Francisco, California $1.88B AUM 16.2% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
EPW
Evolve Private Wealth Los Angeles, California $1.87B AUM
P3I
Progeny 3 Inc Kirkland, Washington $1.87B AUM 30.4% 1-Year Est. Return
LCP
LGT Capital Partners Pfaeffikon, Switzerland $1.88B AUM 20.37% 1-Year Est. Return
TWA
TCI Wealth Advisors Tucson, Arizona $1.88B AUM 21.09% 1-Year Est. Return

Atwood & Palmer's Q2 2022 Portfolio in Review

As of Q2 2022, Atwood & Palmer held 462 positions worth $1.03B, down 11% from $1.16B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Atwood & Palmer's Q2 2022 filing shows 17 new, 58 increased, 119 reduced and 62 closed positions. Its largest new stake was United Therapeutics: 54,788 shares worth $12.9M. The largest sale was iShares Preferred and Income Securities ETF, an estimated $8.97M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 15% a quarter earlier, followed by Technology and Industrials.

  • Atwood & Palmer's largest Q2 2022 buy was United Therapeutics: 54,788 shares worth $12.9M.
  • Atwood & Palmer added most to Garmin in Q2 2022, an estimated $9.3M increase.
  • Atwood & Palmer's biggest Q2 2022 reduction was iShares Preferred and Income Securities ETF, cutting an estimated $8.97M.
  • Atwood & Palmer fully exited Cerner Corp in Q2 2022, selling an estimated $624K.
  • Atwood & Palmer's ten largest holdings make up 30% of its $1.03B portfolio in Q2 2022.
  • Atwood & Palmer opened 17 new positions and closed 62 in Q2 2022.
  • Atwood & Palmer's portfolio value fell 11% quarter-over-quarter to $1.03B.

Based on Atwood & Palmer's 13F filing for Q2 2022, filed 21 Jul 2022.